Agios Appoints David Scadden, M.D., to the Board of Directors
May 31, 2017 20:09 pm UTC| Business
CAMBRIDGE, Mass., May 31, 2017 -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the fields of cancer metabolism and rare genetic diseases, today announced the appointment of David Scadden, M.D., to its board of...
TRACON Pharmaceuticals to Present at the Jefferies 2017 Healthcare Conference
May 31, 2017 20:08 pm UTC| Business
SAN DIEGO, May 31, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
TRACON Pharmaceuticals to Present at the Jefferies 2017 Healthcare Conference
May 31, 2017 20:08 pm UTC| Business
SAN DIEGO, May 31, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
TRACON Pharmaceuticals to Present at the Jefferies 2017 Healthcare Conference
May 31, 2017 20:08 pm UTC| Business
SAN DIEGO, May 31, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
Myriad Genetics to Present at the 2017 William Blair Growth Stock Conference
May 31, 2017 20:08 pm UTC| Business
SALT LAKE CITY, May 31, 2017 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled to present at the...
Myriad Genetics to Present at the 2017 William Blair Growth Stock Conference
May 31, 2017 20:08 pm UTC| Business
SALT LAKE CITY, May 31, 2017 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled to present at the...
Myriad Genetics to Present at the 2017 William Blair Growth Stock Conference
May 31, 2017 20:08 pm UTC| Business
SALT LAKE CITY, May 31, 2017 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled to present at the...
South Africa’s plan to move away from coal: 8 steps to make it succeed
Germany lowers voting age to 16 for the European elections
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects